Every SEC Form 3/4/5 on record for this filer (CIK 1677455) — 5 issuers, 83 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc. | EVP and Chief Legal Officer | 2016-06-22 → 2026-06-15 | 48 | −$10M |
| TNYA | Tenaya Therapeutics, Inc. | Director | 2021-12-23 → 2026-05-29 | 7 | — |
| EOLS | Evolus, Inc. | Director | 2019-07-17 → 2026-02-19 | 11 | −$324,188 |
| ANEB | Anebulo Pharmaceuticals, Inc. | Director · lapsed | 2021-05-06 → 2022-10-03 | 2 | — |
| ARCT | Arcturus Therapeutics Holdings Inc. | Director · lapsed | 2019-06-26 → 2021-06-22 | 4 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| RARE | 2026-06-15 | Sell | 1,899 | $24.62 | $46,753 | 94,462 |
| RARE | 2026-03-10 | Sell | 3,508 | $22.67 | $79,526 | 66,820 |
| RARE | 2026-03-06 | Sell | 6,018 | $21.40 | $128,785 | 70,328 |
| RARE | 2026-03-02 | Sell | 8,135 | $22.80 | $185,478 | 76,346 |
| RARE | 2025-09-12 | Sell | 2,450 | $31.17 | $76,367 | 73,271 |
| EOLS | 2025-03-12 | Sell | 12,888 | $12.99 | $167,415 | 32,183 |
5 of 5 issuers are covered and open a security page; the rest are on file here only.
